Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.
Continue Reading
Sign up for FREE to read the full article and access 146K+ alternative investment headlines.